SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia.

Published in:

Oncogene, 2015, v. 34, n. 5, p. 631, doi. 10.1038/onc.2013.587

By:

• Pasmant, E;
• Gilbert-Dussardier, B;
• Petit, A;
• de Laval, B;
• Luscan, A;
• Gruber, A;
• Lapillonne, H;
• Deswarte, C;
• Goussard, P;
• Laurendeau, I;
• Uzan, B;
• Pflumio, F;
• Brizard, F;
• Vabres, P;
• Naguibvena, I;
• Fasola, S;
• Millot, F;
• Porteu, F;
• Vidaud, D;
• Landman-Parker, J

Publication type:

Article